Kleiman, Anna <br/><br/>
HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors.  [electronic resource] 

 -  International journal of cancer  Jun 2004 
 - 459-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.11649  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies--chemistry<br/>Antibodies, Viral<br/>Blotting, Western<br/>Disease Progression<br/>Endogenous Retroviruses--genetics<br/>Gene Products, env--immunology<br/>Gene Products, gag--immunology<br/>Genetic Therapy--methods<br/>Humans<br/>Neoplasm Metastasis<br/>Neoplasms, Germ Cell and Embryonal--genetics<br/>Proviruses--genetics<br/>Time Factors<br/>Viral Proteins--genetics